Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  PerkinElmer, Inc.    PKI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

PerkinElmer, Inc. : PerkinElmer Board Declares Quarterly Dividend

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/25/2013 | 10:10pm CET

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 25, 2013. This dividend is payable on May 10, 2013, to all shareholders of record at the close of business on April 19, 2013.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,400 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Investor Relations:
PerkinElmer, Inc.
Tommy J. Thomas, 781-663-5889
[email protected]
or
Media Contact:
PerkinElmer, Inc.
Stephanie R. Wasco, 781-663-5701
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PERKINELMER, INC.
11/07 PERKINELMER : Management's Discussion and Analysis of Financial Condition and Re..
11/06 COB LED Market - Evolving Industry trends, size, share estimates & leading in..
11/06 COB LED Market – Evolving Industry trends, size, share estimates & lead..
11/02 PERKINELMER : beats Street 3Q forecasts
11/02 PERKINELMER : Announces Financial Results for the Third Quarter of 2017
11/02 PERKINELMER : Demonstrates the Benefits of High Throughput Screening Platforms t..
11/01 PERKINELMER : Demonstrates the Benefits of High Throughput Screening Platforms t..
10/31 PERKINELMER : Phase II Clinical Trial Data Establishes Effectiveness of using a ..
10/31 PERKINELMER : Phase II Clinical Trial Data Establishes Effectiveness of using a ..
10/30 PERKINELMER INC : Change in Directors or Principal Officers (form 8-K)
More news
News from SeekingAlpha
11/02 PerkinElmer (United States) (PKI) Q3 2017 Results - Earnings Call Transcript
11/02 PerkinElmer beats by $0.01, beats on revenue
11/01 Notable earnings after Thursday?s close
10/27 PerkinElmer declares $0.07 dividend
10/20 LabCorp and Waters attractive tax reform plays - Wells Fargo
Financials ($)
Sales 2017 2 232 M
EBIT 2017 429 M
Net income 2017 344 M
Debt 2017 496 M
Yield 2017 0,39%
P/E ratio 2017 22,77
P/E ratio 2018 25,15
EV / Sales 2017 3,79x
EV / Sales 2018 3,43x
Capitalization 7 970 M
Chart PERKINELMER, INC.
Duration : Period :
PerkinElmer, Inc. Technical Analysis Chart | PKI | US7140461093 | 4-Traders
Technical analysis trends PERKINELMER, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 74,1 $
Spread / Average Target 2,5%
EPS Revisions
Managers
NameTitle
Robert F. Friel Chairman, President & Chief Executive Officer
Frank Anders Wilson Chief Financial Officer & Senior Vice President
Nicholas A. Lopardo Independent Director
Alexis Platon Michas Lead Independent Director
Patrick J. Sullivan Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PERKINELMER, INC.38.66%7 970
THERMO FISHER SCIENTIFIC INC.34.78%75 857
DANAHER19.86%64 900
INTUITIVE SURGICAL85.67%43 977
BOSTON SCIENTIFIC CORPORATION30.65%38 807
ROYAL PHILIPS14.34%36 778